fudosteine has been researched along with Acute Respiratory Distress Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, K; He, G; Hu, J; Li, W; Li, X; Liu, L; Wang, H; Wang, T; Wen, F; Xu, D; Yang, D | 1 |
1 other study(ies) available for fudosteine and Acute Respiratory Distress Syndrome
| Article | Year |
|---|---|
Fudosteine attenuates acute lung injury in septic mice by inhibiting pyroptosis via the TXNIP/NLRP3/GSDMD pathway.
Topics: Acute Lung Injury; Animals; Carrier Proteins; Cystine; Inflammasomes; Lung; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Phosphate-Binding Proteins; Pore Forming Cytotoxic Proteins; Pyroptosis; Respiratory Distress Syndrome; Sepsis; Thioredoxins | 2022 |